Results 11 to 20 of about 5,217,497 (361)

Ovarian Cancer Immunotherapy and Personalized Medicine

open access: yesInternational Journal of Molecular Sciences, 2021
Ovarian cancer response to immunotherapy is limited; however, the evaluation of sensitive/resistant target treatment subpopulations based on stratification by tumor biomarkers may improve the predictiveness of response to immunotherapy.
Susan Morand   +4 more
semanticscholar   +1 more source

Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems

open access: yesJournal of Ovarian Research, 2023
Epithelial ovarian cancer (EOC) research has become more complex as researchers try to fully understand the metastatic process. Especially as we delve into the concept of tumour dormancy, where cells transition between proliferative and dormant states to
Emily Tomas, Trevor G. Shepherd
doaj   +1 more source

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

open access: yesBMC Cancer, 2017
Background Epithelial ovarian cancer exhibits extensive interpatient and intratumoral heterogeneity, which can hinder successful treatment strategies.
Jessica G. Tong   +7 more
doaj   +1 more source

Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer. [PDF]

open access: yes, 2015
The objective of this study was to evaluate the correlation between 25-OH vitamin D and ovarian cancer as a diagnostic marker or recurrence disease marker.
Anastasi, Emanuela   +6 more
core   +1 more source

Ovarian cancer statistics, 2018

open access: yesCa, 2018
In 2018, there will be approximately 22,240 new cases of ovarian cancer diagnosed and 14,070 ovarian cancer deaths in the United States. Herein, the American Cancer Society provides an overview of ovarian cancer occurrence based on incidence data from ...
Lindsey A. Torre   +8 more
semanticscholar   +1 more source

HE4 in the differential diagnosis of ovarian masses [PDF]

open access: yes, 2015
Ovarian masses, a common finding among pre- and post-menopausal women, can be benign or malignant. Ovarian cancer is the leading cause of death from gynecologic malignancy among women living in industrialized countries.
ANASTASI, Emanuela   +5 more
core   +1 more source

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.

open access: yesPLoS Medicine, 2012
BackgroundOnly about half the studies that have collected information on the relevance of women's height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent.
Collaborative Group on Epidemiological Studies of Ovarian Cancer
doaj   +1 more source

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

open access: yesScience, 1994
A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been identified by positional cloning methods.
Y. Miki   +44 more
semanticscholar   +1 more source

The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation

open access: yesNucleic Acids Research, 2020
N 6-Methyladenosine (m6A) is the most abundant RNA modification in mammal mRNAs and increasing evidence suggests the key roles of m6A in human tumorigenesis.
Tao Liu   +17 more
semanticscholar   +1 more source

The association between hysterectomy and ovarian cancer risk: A population-based record-linkage study [PDF]

open access: yes, 2019
Background: Recent studies have called into question the long-held belief that hysterectomy without oophorectomy protects against ovarian cancer. This population-based longitudinal record-linkage study aimed to explore this relationship, overall and by ...
Dixon-Suen, Suzanne C   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy